KALA BIO, Inc. cotiza a 0.26 USD y tiene una capitalización bursátil de $5M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI deployment. Its platfor…
| Periodo | 2025-11 | 2025-08 | 2025-05 | 2025-03 |
|---|---|---|---|---|
| Real | $-53.50 | $-65.94 | $-50.66 | $-61.58 |
| Estimado | $-50.50 | $-102.00 | $-127.00 | $-123.50 |
| Sorpresa | -5.9% | +35.4% | +60.1% | +50.1% |
| Métrica | KALA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -385.6% | -40.4% | -345.3% |
| ROA | -284.3% | -32.0% | -252.3% |
| Current Ratio | 3.81 | 2.84 | +0.97 |
| Debt / Equity | — | 0.28 | — |